Clinical Trials Directory

Trials / Completed

CompletedNCT02474342

Autologous Adipose Tissue Derived Mesenchymal Stem Cells for Rotator Cuff Disease

Safety and Efficacy of Autologous Adipose Tissue Derived Mesenchymal Stem Cells Transplantation in Patient With Rotator Cuff Disease

Status
Completed
Phase
N/A
Study type
Interventional
Enrollment
18 (actual)
Sponsor
Seoul National University Hospital · Academic / Other
Sex
All
Age
19 Years
Healthy volunteers
Not accepted

Summary

The purpose of this study is to evaluate safety and efficacy of Autologous Adipose Tissue Derived Mesenchymal Stem Cells injection in patient with Rotator Cuff disease.

Conditions

Interventions

TypeNameDescription
BIOLOGICALAutologous Adipose Tissue Derived MSCs Transplantation1. Study drugs: Autologous adipose tissue derived MSCs 2. Injection dosage and volume of the study drugs: * Low dose: 1x10e7 cells/3mL 3. Number of injections : only once during the study period 4. Device: Ultrasound 5. Injection technique: Injection into the lesion by investigator
BIOLOGICALAutologous Adipose Tissue Derived MSCs Transplantation1. Study drugs: Autologous adipose tissue derived MSCs 2. Injection dosage and volume of the study drugs: * Mid dose: 5x10e7 cells/3mL 3. Number of injections : only once during the study period 4. Device: Ultrasound 5. Injection technique: Injection into the lesion by investigator
BIOLOGICALAutologous Adipose Tissue Derived MSCs Transplantation1. Study drugs: Autologous adipose tissue derived MSCs 2. Injection dosage and volume of the study drugs: * High dose: 1x10e8 cells/3mL 3. Number of injections : only once during the study period 4. Device: Ultrasound 5. Injection technique: Injection into the lesion by investigator

Timeline

Start date
2015-07-07
Primary completion
2016-11-01
Completion
2016-11-07
First posted
2015-06-17
Last updated
2017-03-07

Locations

1 site across 1 country: South Korea

Source: ClinicalTrials.gov record NCT02474342. Inclusion in this directory is not an endorsement.